ACADIA Pharmaceuticals Inc. (ACAD)

ACADIA Pharmaceuticals Market Cap

ACADIA Pharmaceuticals has a market cap or net worth of $3.68 billion as of May 6, 2026. Its market cap has increased by 53.34% in one year.

• Market Cap: 3.68B
• Enterprise Value: 2.87B
• 1-Year Change: 53.34%
• Ranking: #1622
• Category: Mid-Cap
• Stock Price: $21.48

Market Cap Chart

Since May 27, 2004, ACADIA Pharmaceuticals's market cap has increased from $112.80M to $3.68B, an increase of 3,160.38%. That is a compound annual growth rate of 17.20%.

Market Cap History

Date	Market Cap	% Change
May 5, 2026	3.81B	-15.67%
Dec 31, 2025	4.52B	48.00%
Dec 31, 2024	3.05B	-40.60%
Dec 29, 2023	5.14B	99.41%
Dec 30, 2022	2.58B	-31.29%
Dec 31, 2021	3.75B	-55.85%
Dec 31, 2020	8.50B	28.98%
Dec 31, 2019	6.59B	225.79%
Dec 31, 2018	2.02B	-45.92%
Dec 29, 2017	3.74B	7.07%
Dec 30, 2016	3.49B	-2.91%
Dec 31, 2015	3.60B	13.57%
Dec 31, 2014	3.17B	39.50%
Dec 31, 2013	2.27B	762.44%
Dec 31, 2012	263.30M	361.93%
Dec 30, 2011	57.00M	20.76%
Dec 31, 2010	47.20M	-6.53%
Dec 31, 2009	50.50M	51.20%
Dec 31, 2008	33.40M	-91.84%
Dec 31, 2007	409.20M	56.24%
Dec 29, 2006	261.90M	13.18%
Dec 30, 2005	231.40M	102.63%
Dec 31, 2004	114.20M	1.24%
May 27, 2004	112.80M	-

View and export this data all the way back to 2004. Sign Up Today.

Related Stocks

Company	Market Cap
Travere Therapeutics	4.16B
Edgewise Therapeutics	3.98B
Viking Therapeutics	3.75B
Telix Pharmaceuticals	3.73B
Catalyst Pharmaceuticals	3.73B
NewAmsterdam Pharma Company	3.57B
Tango Therapeutics	3.41B
Erasca	3.39B